Uganda begins largest trial of experimental Ebola vaccine
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Monday
January 30, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
MONDAY, JANUARY 30, 2023
Uganda begins largest trial of experimental Ebola vaccine

World+Biz

TBS Report
03 August, 2019, 10:05 am
Last modified: 03 August, 2019, 10:11 am

Related News

  • Elon Musk: Tweets about taking Tesla private weren't fraud
  • Nobel Prize-winning rights defender goes on trial in Belarus
  • Nine suffocate to death in Ugandan New Year firework crush - police
  • J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies
  • Ebola vaccine candidates arrive in Uganda for trials

Uganda begins largest trial of experimental Ebola vaccine

Ugandan researchers said the new trial is expected to last two years and will test how long any protection from Ebola would last.

TBS Report
03 August, 2019, 10:05 am
Last modified: 03 August, 2019, 10:11 am
Uganda begins largest trial of experimental Ebola vaccine

Researchers in Uganda have launched the largest-ever trial of the experimental Ebola vaccine that is expected to be deployed in neighboring Congo, where a deadly outbreak has killed over 1,800 people.

The trial of the Janssen Pharmaceuticals vaccine involves up to 800 people in the western district of Mbarara and is supported by Doctors without Borders and the London School of Hygiene and Tropical Medicine.

Ponciano Kaleebu, a Ugandan researcher who leads the trial, said Friday that he regrets that the Janssen vaccine has not yet been deployed in Congo. The health minister there who stepped down last month had argued against its deployment, saying a second vaccine could create confusion on the ground.

Already more than 180,000 people in Congo’s yearlong outbreak have received an experimental but effective Merck vaccine, but health experts worry about the availability of doses as the virus now spreads in a major city, Goma, along the Rwanda border. The wife and 1-year-old daughter of the man who died this week of Ebola in Goma now have the disease.

Both the wife and child were doing well in treatment, Congo’s new Ebola response coordinator, Jean-Jacques Muyembe, told reporters on Friday.

But he warned that about half of the cases in this outbreak are going undetected and at that rate “this epidemic could last two or three years.” The current goal is to strengthen surveillance and bring the detection rate to 80%, he said.

Health experts have watched with dismay as the promise of the Merck vaccine in this outbreak has been largely overshadowed by severe challenges to virus containment efforts including rebel attacks and community resistance in a part of Congo that had never experienced Ebola before.

The Janssen vaccine has already been tested in about 6,000 people, most of them Africans, Kaleebu said. “We are excited about this (trial) ... because this is one of the promising vaccines,” he said. “It’s one of those vaccines that have shown a lot of promise in animal studies but also in other trials that have been conducted.”

Ugandan researchers said the new trial is expected to last two years and will test how long any protection from Ebola would last. Juliet Mwanga, a co-investigator on the trial, said there is the need “to study many vaccines” in light of Congo’s epidemic.

Uganda has had multiple Ebola outbreaks in the past. While it is currently free of the virus, three people died in June after crossing into the country’s Kasese district on an unguarded footpath. Their family members were taken back to Congo for treatment.

The Ebola virus can spread quickly and be fatal in up to 90% of cases. Symptoms include fever, vomiting, diarrhea, muscle pain and at times internal and external bleeding. The virus is most often spread by close contact with bodily fluids of people exhibiting symptoms and with contaminated objects such as sheets. Health care workers are often at risk.

Top News

Ebola / Uganda / Trial

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Collected
    Economic slump drags down growth in VAT collection from big cos
  • It's corruption that bites business harder: CPD
    It's corruption that bites business harder: CPD
  • Import slowdown to affect economic growth: ADB country head
    Import slowdown to affect economic growth: ADB country head

MOST VIEWED

  • A woman on a mobility scooter drives past a mural praising the NHS (National Health Service) amidst the continuation of the coronavirus disease (COVID-19) pandemic, London, Britain, March 5, 2021. REUTERS/Toby Melville/File Photo
    Hundreds of thousands of UK healthcare workers balloted for strikes
  • FILE PHOTO: A general view shows the Island of Kunashir, one of four islands known as the Southern Kuriles in Russia and the Northern Territories in Japan, December 20, 2016. REUTERS/Yuri Maltsev/File Photo
    Russia rules out talks with Japan on fishing near disputed islands
  • Chief Executive of oil producer Rosneft Igor Sechin attends a meeting with Russian President Vladimir Putin at the Novo-Ogaryovo state residence outside Moscow, Russia February 15, 2021. Sputnik/Mikhail Klimentyev/Kremlin via REUTERS/File Photo
    Russia's Sechin says Taiwan will return to China 'on schedule'
  • FILE PHOTO: US Representative Michael McCaul (R-TX) arrives at Trump Tower to meet with US President-elect Donald Trump in New York, US, November 29, 2016. REUTERS/Mike Segar/File Photo
    Odds 'very high' of US military conflict with China, top Republican says
  • China's and U.S.' flags are seen printed on paper in this illustration taken January 27, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
    China says willing to communicate with US military but 'red lines' should be respected
  • Photo: Reuters
    UAE museum unveils Torah scroll that survived the Holocaust in tolerance push

Related News

  • Elon Musk: Tweets about taking Tesla private weren't fraud
  • Nobel Prize-winning rights defender goes on trial in Belarus
  • Nine suffocate to death in Ugandan New Year firework crush - police
  • J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies
  • Ebola vaccine candidates arrive in Uganda for trials

Features

Nandita Sharmin's journey to give organic skincare a new identity

Nandita Sharmin's journey to give organic skincare a new identity

18h | Mode
Illustration: TBS

'The silver lining is that the worst is sort of behind us': Hamid Rashid, UN economist

22h | Panorama
Photo: Bloomberg

BuzzFeed and AI are a match made in fad city

21h | Panorama
Snipe in flight. Photo: Enam Ul Haque

Baikka Beel: 'A world where snipe work late'

1d | Panorama

More Videos from TBS

Sarika Sabrin is waiting for a good film

Sarika Sabrin is waiting for a good film

12h | TBS Entertainment
Take your football game to the next level at Next Level academy

Take your football game to the next level at Next Level academy

13h | TBS SPORTS
“Investments risky without consistent policy, reliable data”- SK Bashir Uddin

“Investments risky without consistent policy, reliable data”- SK Bashir Uddin

15h | TBS Round Table
What does Shahrukh has in his 770 million dollar property?

What does Shahrukh has in his 770 million dollar property?

1d | TBS Entertainment

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

3
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

4
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

5
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]